Dr. Federico Cappuzzo, MD, PhD

Name: Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum
Start: 2025-09-07T18:30:00+02:00
End: 2025-09-07T19:30:00+02:00

April 1, 2016

|

By

|

Estimated Read Time:

1 minute

Names & News

Dr. Federico Cappuzzo, has been appointed as the new Director of Medical Oncology at Azienda Unità Sanitaria Locale (AUSL) della Romagna in Ravenna, Italy. Dr. Cappuzzo was previously the Director of the Medical Oncology Department at the Ospedale Civile, Livorno.

About the Authors

Share this Article:

Dr. Federico Cappuzzo, MD, PhD

Recent Posts

Meet Us in Barcelona: What to Expect at the World Conference on Lung Cancer

Celebrate the IASLC Foundation’s Impact

Step it Up at WCLC 2025 in Barcelona

Know Before You Go: Your Guide to Navigating Barcelona

IS03: Satellite EBAC/CME Symposium by Answers in CME: Reshaping the Management of Metastatic NSCLC: Tackling HER2 Overexpression to Elevate Outcomes

Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC